ArticleAntioxidants (Basel, Switzerland)2026
Elevated Amniotic Fluid 8-Iso-Prostaglandin F
Miguel Arráez, Marta Camprubí-Camprubí, María C Escobar-Diaz, Laura Guirado, Laura Nogué, Mar Bennasar, Narcís Masoller, Fàtima Crispi, María Dolores Gómez-Roig, Olga Gómez and 1 more
Abstract read
In one paragraphArticle in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Miguel ArráezBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.ORCID 0000-0002-7071-3829 Laura GuiradoBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.
Laura NoguéBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.ORCID 0000-0001-6938-9104 Mar BennasarBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.ORCID 0000-0003-3935-1935 Narcís MasollerBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.ORCID 0000-0003-4159-7811 Fàtima CrispiBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.ORCID 0000-0002-7422-5240 María Dolores Gómez-RoigBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.
Olga GómezBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.ORCID 0000-0003-4183-9876 Míriam Pérez-CruzBCNatal Fetal Medicine Research Center (Hospital Clínic and Hospital Sant Joan de Déu), 08950 Barcelona, Spain.
Funding
Instituto de Salud Carlos III INT25/00064Instituto de Salud Carlos III PI19/00118Instituto de Salud Carlos III PI22/00754Instituto de Salud Carlos III PI23/00104Instituto de Salud Carlos III PI23/00633Instituto de Salud Carlos III PI24/00127Instituto de Salud Carlos III PI24/00653Instituto de Salud Carlos III RICORS-SAMID, RD24/0013/0004
6 · The paper itselfAbstract
Advances in prenatal diagnosis have improved the perinatal management of congenital heart disease (CHD). However postnatal comorbidities still persist due to multifactorial causes, which limits prenatal prediction of individual outcomes. Oxidative stress (OS), particularly lipid peroxidation, has been suggested to play a role in the development and progression of CHD, with 8-iso-prostaglandin F
Indexed as
8-iso-prostaglandin F2αamniotic fluidcongenital heart diseaseF2-isoprostanesfetal biomarkerslipid peroxidationoxidative stressprenatal diagnosis
Identifiers
PMID42193208
PMCPMC13203179
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390